Multi-iteration testing methodology for leading bio-pharmaceutical company


Abstract

The evolving regulatory environment has mandated the adoption of an Aggregate Spend Program for the life sciences industry. A leading biopharmaceutical company wanted ETL/DW & BI testing of their Aggregate spend solution. Know how Cigniti initiated multi-iteration testing methodology to achieve quick test cycles, thorough testing, and defect reduction.

Download the Collateral




By continuing to use this website, you agree to our cookie & privacy policy.